科塞尔医疗 focuses on research, development and manufacturing of vascular interventional devices and provides integrated system solutions for clinicians. The company concentrates on peripheral intervention, cardiac electrophysiology, and coronary intervention innovative devices. Several peripheral innovative products are reported to be approaching clinical trial entry. Its first innovative medical device, the umbrella-shaped vena cava filter Octoparms®, has received market approval. The company recently completed a financing round, indicating an injection of capital to support its ongoing R&D and production efforts. No operating metrics (revenue/users) or founding year were disclosed in the article.

Total raised

$14M

Funding rounds

1

Latest round

Series B

Latest activity

Dec 2023